These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35494002)

  • 1. Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
    Che L; Paliogiannis P; Cigliano A; Pilo MG; Chen X; Calvisi DF
    Front Oncol; 2022; 12():874053. PubMed ID: 35494002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
    Che L; Paliogiannis P; Cigliano A; Pilo MG; Chen X; Calvisi DF
    Front Oncol; 2019; 9():1412. PubMed ID: 31921669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
    Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
    Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
    Lin HP; Cheng ZL; He RY; Song L; Tian MX; Zhou LS; Groh BS; Liu WR; Ji MB; Ding C; Shi YH; Guan KL; Ye D; Xiong Y
    Cancer Res; 2016 Dec; 76(23):6924-6936. PubMed ID: 27758890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma.
    Liu Q; Dong X
    J Hepatocell Carcinoma; 2021; 8():19-21. PubMed ID: 33537248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.
    Che L; Pilo MG; Cigliano A; Latte G; Simile MM; Ribback S; Dombrowski F; Evert M; Chen X; Calvisi DF
    Cell Cycle; 2017 Mar; 16(6):499-507. PubMed ID: 28118080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
    Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
    Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2021; 11():843623. PubMed ID: 35111689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
    Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.
    Han C; Chen J; Huang J; Zhu R; Zeng J; Yu H; He Z
    Front Oncol; 2023; 13():1162375. PubMed ID: 36969048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARĪ± pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.
    Cao D; Song X; Che L; Li X; Pilo MG; Vidili G; Porcu A; Solinas A; Cigliano A; Pes GM; Ribback S; Dombrowski F; Chen X; Li L; Calvisi DF
    Liver Int; 2017 Jan; 37(1):80-89. PubMed ID: 27264722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
    Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():979968. PubMed ID: 36072794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2023; 13():1134139. PubMed ID: 37025598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study.
    Isowa M; Hamaguchi R; Narui R; Morikawa H; Wada H
    Front Oncol; 2023; 13():1291026. PubMed ID: 37799473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis
    Wen J; Aili A; Yan YX; Lai Y; Niu S; He S; Zhang X; Zhang G; Li J
    Front Oncol; 2022; 12():1038279. PubMed ID: 36387066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridine derivatives as anticancer lead compounds with Fatty Acid Synthase as the target: An in silico-guided in vitro study.
    Amrutha NA; Archana PR; Mohan SG; Anto RJ; Sadasivan C
    J Cell Biochem; 2019 Oct; 120(10):16643-16657. PubMed ID: 31095793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA.
    Yang W; Li Z; Qin R; Wang X; An H; Wang Y; Zhu Y; Liu Y; Cai S; Chen S; Sun T; Meng J; Yang C
    Front Oncol; 2021; 11():828861. PubMed ID: 35096629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.